Updated Jul 16, 2026
Dar Zavain has filed 2 SEC Form 4 filings across 1 company in the last 90 days.
Zavain Dar is a corporate director at Recursion Pharmaceuticals, Inc., a clinical-stage biotechnology company focused on drug discovery. He has been involved in multiple SEC filings related to his role at the company.
| Role | Director |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-02 | RXRX | RECURSION PHARMACEUTICALS, INC. | A — Grant or award | 5.1K | $0.00 | |
| 2026-06-22 | RXRX | RECURSION PHARMACEUTICALS, INC. | A — Grant or award | 88.4K | $0.00 | |
| 2026-04-02 | RXRX | RECURSION PHARMACEUTICALS, INC. | A — Grant or award | 4.9K | $0.00 | |
| 2025-10-01 | RXRX | RECURSION PHARMACEUTICALS, INC. | A — Grant or award | 2.9K | $0.00 | |
| 2025-07-01 | RXRX | RECURSION PHARMACEUTICALS, INC. | A — Grant or award | 2.9K | $0.00 | |
| 2024-10-04 | RXRX | RECURSION PHARMACEUTICALS, INC. | A — Grant or award | 2.2K | $0.00 |
Zavain Dar is a corporate director at Recursion Pharmaceuticals, Inc., a clinical-stage biotechnology company focused on drug discovery. He has been involved in multiple SEC filings related to his role at the company.…
2 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Dar Zavain profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.